Last reviewed · How we verify
Sunitinib malate capsules generic product — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Sunitinib malate capsules generic product (Sunitinib malate capsules generic product) — Chia Tai Tianqing Pharmaceutical Group Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sunitinib malate capsules generic product TARGET | Sunitinib malate capsules generic product | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sunitinib malate capsules generic product CI watch — RSS
- Sunitinib malate capsules generic product CI watch — Atom
- Sunitinib malate capsules generic product CI watch — JSON
- Sunitinib malate capsules generic product alone — RSS
Cite this brief
Drug Landscape (2026). Sunitinib malate capsules generic product — Competitive Intelligence Brief. https://druglandscape.com/ci/sunitinib-malate-capsules-generic-product. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab